spacer
home > epc > spring 2018 > a winning formula
PUBLICATIONS
European Pharmaceutical Contractor

A Winning Formula

Considerable discussion has been had about the concept of patient centricity in the pharmaceutical community. The industry has taken a collective pause in an effort to re-evaluate longstanding approaches to drug development and commercialisation, with attention being recalibrated on the ultimate goal: making reaching improved health outcomes easier for the patient. This perspective is underpinned by the recognition that what is best for the patient will lead to beneficial outcomes for all stakeholders, including the drug company, the healthcare provider, and supporting community of associated service providers.

A famous quote from former US Surgeon General, C Everett Koop states “Drugs don’t work in people who don’t take them”. Less than one-third of all prescriptions written are estimated to be filled at the pharmacy by patients. Wide-ranging studies have shown medication adherence rates for life-threatening diseases including diabetes, heart disease, and oncology can be as low as 30-40%. With the benefit of interventional techniques and developing technologies, adherence rates have been shown to improve. However, these programmes are not broadly adopted with scale and have not had significant impact decreasing the overall cost of healthcare nor benefitted large populations.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Justin Schroeder is Senior Executive Director of global marketing and design at PCI Pharma Services. He is responsible for global marketing, creative package design, and new account development, with a focus on the development and commercialisation of new products. Justin has over 20 years of experience in outsourced pharma services in various roles, including engineering, project management, marketing, and development. He holds a Bachelor of Science from the School of Packaging at Michigan State University, US, and an MBA in marketing from Northern Illinois University, US. Justin is a certified Packaging Professional from the Institute of Packaging Professionals, US, and is the Vice Chairman of the US Healthcare Compliance Packaging Council.
spacer
Justin Schroeder
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Pharma Services Announces Agreement to Acquire Sherpa Clinical Packaging

Philadelphia, USA – September 10, 2018 Leading global biopharmaceutical outsourcing services provider PCI Pharma Services (PCI) is pleased to announce the acquisition of San Diego-based Sherpa Clinical Packaging (Sherpa), which expands PCI’s U.S. operations to the West Coast. The acquisition of Sherpa, a provider of clinical trial supply services, further strengthens PCI’s position as a leader in outsourced clinical trial support services. The addition of Sherpa’s capabilities also enables PCI to better support customers from early phases of clinical development through to commercial launch.
More info >>

White Papers

Key to Outsourcing Method Development and Validation A Pragmatic Approach

RSSL

In an industry that is seeing an increasing level of work being outsourced, the Contract Research Organisation (CRO) of choice needs to have proven experience in both the pragmatism and flexibility of the method developer’s mind set and a regulatory background in validation.
More info >>

 
Industry Events

Pharma and Device Packaging and Labelling West Coast 2018

27-28 November 2018, Burlingame, CA

The second edition of the Pharma and Device Packaging and Labeling West Coast was a thought-provoking two days of engaging presentations, discussion and networking.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement